Exemestane encapsulated copolymers L121/F127/GL44 based mixed micelles: solubility enhancement and in vitro cytotoxicity evaluation using MCF-7 breast cancer cells
Authors:
- 30 July 2021
- journal article
- research article
- Published by Springer Nature in Journal of Pharmaceutical Investigation
- Vol. 51 (6) , 701-714
Abstract
No abstract availableKeywords
This publication has 37 references indexed in Scilit:
- Polymeric Micelles, a Promising Drug Delivery System to Enhance Bioavailability of Poorly Water-Soluble DrugsJournal of Drug Delivery, 2013
- The potential of Pluronic polymeric micelles encapsulated with paclitaxel for the treatment of melanoma using subcutaneous and pulmonary metastatic mice modelsBiomaterials, 2011
- Aromatase, aromatase inhibitors, and breast cancerThe Journal of Steroid Biochemistry and Molecular Biology, 2011
- Tumor delivery of macromolecular drugs based on the EPR effectAdvanced Drug Delivery Reviews, 2011
- Alternative oral exemestane formulation: Improved dissolution and permeationInternational Journal of Pharmaceutics, 2010
- Hydrotropic polymer micelles containing acrylic acid moieties for oral delivery of paclitaxelJournal of Controlled Release, 2008
- Cancer survival in five continents: a worldwide population-based study (CONCORD)The Lancet Oncology, 2008
- Are aromatase inhibitors superior to antiestrogens?The Journal of Steroid Biochemistry and Molecular Biology, 2005
- Polymeric micelles – a new generation of colloidal drug carriersEuropean Journal of Pharmaceutics and Biopharmaceutics, 1999
- Micelles based on AB block copolymers of poly(ethylene oxide) and poly(.beta.-benzyl L-aspartate)Langmuir, 1993